113 - Antimicrobial Stewardship Programs in Latin America and the Caribbean

Friday, October 18, 2024

10:30 AM – 11:45 AM US PT

Location: 515 B

All relevant financial relationships have been mitigated.

CME Credits: Maximum of 1.25 hours of AMA PRA Category 1 Credit™
MOC Credits: Maximum of 1.25 hours of MOC Credit
CNE Credits: Maximum of 1.25 hours of ANCC Credit
ACPE Credits: ACPE 1.25 knowledge-based contact hours of pharmacy CE
ACPE Number: JA0007082-9999-24-002-L01-P
PACE Credits: Maximum of 1 of PACE contact hours
CE Broker: Maximum of 1 CE broker credit hours

Moderator(s)

Leila Hojat, MD, MS (she/her/hers)

Assistant Professor
Medicine
Case Western Reserve University/ University Hospitals Cleveland Medical Center
Cleveland, OH, United States
Carlos Franco-Paredes, MD, MPH

Faculty
Department of Medicine - Division of Infectious Diseases
Hospital Infantil de Mexico, Mexico and Instituto Conmemorativo de la Salud, Panama
Denver, CO, United States
AM

Abiel Mascarenas

Faculty(s)

Pilar Ramon-Pardo, MD, PhD (she/her/hers)

Dr. Pilar Ramon-Pardo
PAHO/WHO
Washington DC, DC, United States
Guadalupe Perez, MD, PID, PhD (she/her/hers)

Pediatrics Infectious Diseases Physician. Coordinator of Antimicrobial Stewardship Program
Epidemiology and Infectious Diseases Department. Hospital de Pediatria Garrahan, Ciudad Autonoma de Buenos Aires, Argentina
José Díaz Madriz, PharmD, MSc (he/him/his)

Clinical Pharmacist, Pharmacology Specialist Clinical Pharmacy and Antimicrobial Stewardship Coordinator
Pharmacy Department, Clínica Bíblica, San José, Costa Rica

Disclosure(s):

Leila S. Hojat, MD, MS: No financial relationships to disclose

Carlos Franco-Paredes, MD, MPH: No financial relationships to disclose

Abiel Mascarenas: No financial relationships to disclose

Pilar Ramon-Pardo, MD, PhD: No financial relationships to disclose

Guadalupe Perez, MD, PID, PhD: No financial relationships to disclose

José Pablo Díaz Madriz, PharmD, MSc: Eli Lilly: Stocks/Bonds (Private Company) (Ongoing); MSD Central America Services S. De R.L: Advisor/Consultant (Terminated, January 25, 2024); Pfizer Zona Franca SA: Advisor/Consultant (Terminated, October 4, 2023)

Learning Objectives:

At the conclusion of this session, participants will be able to:

describe initiatives for the optimization of containment of antimicrobial resistance in latam;
explain the role of pharmacists in designing, implementing, and monitoring antimicrobial stewardship programs in latam,
describe the determinants of misuse of antibiotics in hospitals.

Presentations:

10:30 AM – 10:55 AM US PT

Advancing Antimicrobial Stewardship: Strategies for Optimizing Containment of Antimicrobial Resistance in Latin America and the Caribbean
Speaker: Pilar Ramon-Pardo, MD, PhD (she/her/hers) – PAHO/WHO
10:55 AM – 11:20 AM US PT

Determinants of misuse of antibiotics in hospitals
Speaker: Guadalupe Perez, MD, PID, PhD (she/her/hers) – Epidemiology and Infectious Diseases Department. Hospital de Pediatria Garrahan
11:20 AM – 11:45 AM US PT

Role of pharmacists in antimicrobial stewardship programs in LATAM
Speaker: José P. Díaz Madriz, PharmD, MSc (he/him/his) – Pharmacy Department, Clínica Bíblica, San José